Esperion Therapeutics, Inc. (ESPR):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH185154FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Esperion Therapeutics, Inc. (Esperion) is a biotechnology company. The company develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion’s products include ETC-1002, ESP41091, 4WF, and HDL Mimetics. Its ETC-1002 is an oral drug for patients who have/are at risk for developing, cardiovascular and metabolic diseases. The company’s second generation compounds impacts lipid and carbohydrate metabolism and inflammation; and HDL mimetic therapies are designed to rapidly eliminate cholesterol and other lipids from the arterial wall and related tissues. The company operates as a subsidiary of Pfizer Inc. Esperion is headquartered in Plymouth, Michigan, the US.

Esperion Therapeutics, Inc. Key Recent Developments

Dec 23, 2013: Esperion Therapeutics Added to the NASDAQ Biotechnology Index
Nov 06, 2013: Esperion Therapeutics Reports Third Quarter 2013 Financial Results
Nov 05, 2013: Esperion Therapeutics to Present at Credit Suisse Healthcare Conference
Sep 24, 2013: Esperion Therapeutics to Present at BioCentury Newsmakers in the Biotech Industry Conference
Sep 10, 2013: Esperion Therapeutics to Present at Stifel Nicolaus 2013 Healthcare Conference

This comprehensive SWOT profile of Esperion Therapeutics, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Esperion Therapeutics, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Esperion Therapeutics, Inc. – Key Information
Esperion Therapeutics, Inc. – Overview
Esperion Therapeutics, Inc. – Key Employees
Esperion Therapeutics, Inc. – Key Employee Biographies
Esperion Therapeutics, Inc. – Key Operational Heads
Esperion Therapeutics, Inc. – Major Products and Services
Esperion Therapeutics, Inc. – History
Esperion Therapeutics, Inc. – Company Statement
Esperion Therapeutics, Inc. – Locations And Subsidiaries
Esperion Therapeutics, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Esperion Therapeutics, Inc. – Business Description
Esperion Therapeutics, Inc. – Corporate Strategy
Esperion Therapeutics, Inc. – SWOT Analysis
SWOT Analysis – Overview
Esperion Therapeutics, Inc. – Strengths
Esperion Therapeutics, Inc. – Weaknesses
Esperion Therapeutics, Inc. – Opportunities
Esperion Therapeutics, Inc. – Threats
Esperion Therapeutics, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Esperion Therapeutics, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Esperion Therapeutics, Inc., Key Information
Esperion Therapeutics, Inc., Key Ratios
Esperion Therapeutics, Inc., Share Data
Esperion Therapeutics, Inc., Major Products and Services
Esperion Therapeutics, Inc., History
Esperion Therapeutics, Inc., Key Employees
Esperion Therapeutics, Inc., Key Employee Biographies
Esperion Therapeutics, Inc., Key Operational Heads
Esperion Therapeutics, Inc., Other Locations
Esperion Therapeutics, Inc., Subsidiaries
Esperion Therapeutics, Inc., Key Manufacturing facilities
Esperion Therapeutics, Inc., Key Competitors
Esperion Therapeutics, Inc., SWOT Analysis
Esperion Therapeutics, Inc., Ratios based on current share price
Esperion Therapeutics, Inc., Annual Ratios
Esperion Therapeutics, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Esperion Therapeutics, Inc., Performance Chart
Esperion Therapeutics, Inc., Ratio Charts

★海外企業調査レポート[Esperion Therapeutics, Inc. (ESPR):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wuhan Kaidi Electric Power Co. Ltd. (000939):企業概要、財務及び戦略的SWOT分析
    Summary Wuhan Kaidi Electric Power Co., Ltd. (Wuhan Kaidi) is a renewable energy service provider. The company develops technologies and products for the protection of environment. Its services include environmental protection, new energy and power engineering, technology development and application …
  • Advanced Logistics Development (ALD):企業財務及び戦略的SWOT分析
    Summary Advanced Logistics Development (ALD) is a software consulting firm that offers professional consulting, software development, and training services. The firm provides software products such as RAM commander, FavoWeb, D-LCC, SPC, FacoScope and ALDCollege course management software system. Its …
  • Ascopiave S.p.A. (ASC):企業財務及び戦略的SWOT分析
    Summary Ascopiave S.p.A. (Ascopiave) is a power distribution company that supplies natural gas, electricity, and alternative energy. The company maintains natural gas pipes network to supply natural gas. It owns and operates managed distribution network that offers its service in several municipalit …
  • TDS Telecommunications Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TDS Telecommunications Corporat …
  • Nigerian National Petroleum Corporation:企業の戦略的SWOT分析
    Nigerian National Petroleum Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Jardine Lloyd Thompson Group plc:企業の戦略・SWOT・財務分析
    SummaryJardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • R-Pharm:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' R-Pharm Mergers and Acquisition …
  • Cresco Ltd. (4674):企業概要、財務及び戦略的SWOT分析
    Summary Cresco Ltd. (Cresco) is a software development company. The company develops and markets business software for corporate computer systems. It operates through divisions such as application development, IT infrastructure architecture and embedded systems. Cresco’s IT infrastructure architectu …
  • Dawnrays Pharmaceutical (Holdings) Limited (2348):企業概要、財務及び戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Limited (Dawnrays) is a pharmaceutical company. The company develops, manufactures and markets cephalosporin antibiotics and specific medicines to healthcare markets. Its products include cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium …
  • Invicta Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Invicta Group, Inc. Mergers and …
  • Meda AB (MEDA A):企業概要、財務及び戦略的SWOT分析
    Summary Meda AB (Meda) is a specialty pharmaceutical company. It develops, manufactures and markets specialty products, OTC (non-prescription products) and branded generics. The company develops drugs for cardiac conditions, pain and inflammation, central nervous system diseases, gastroenterological …
  • Deep Well Oil & Gas, Inc. (DWOG):企業概要、財務及び戦略的SWOT分析
    Summary Deep Well Oil & Gas, Inc. (Deep Well Oil & Gas) is an oil and gas exploration and development company. The company acquires, explores and produces crude oil and natural gas. It has exploration permit in 56 sections on seven oil sands leases and more 12 sections on two oil sands leases in the …
  • JTEKT Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JTEKT Corporation Mergers and A …
  • Aishwarya Technologies and Telecom Ltd (532975):企業概要、財務及び戦略的SWOT分析
    Summary Aishwarya Technologies and Telecom Ltd (ATTL) formerly Aishwarya Telecom Ltd, is a telecommunication service provider. The company manufactures fibre optic test equipments and cable fault locators. Its products include optical power meter, optical laser source, handheld optical multimeter, o …
  • ILandFS Transportation Networks Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ILandFS Transportation Networks …
  • The Sherwin-Williams Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Sherwin-Williams Company Me …
  • MedQuist, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MedQuist, Inc. Mergers and Acqu …
  • Petrodorado Energy Ltd. (PDQ):企業財務及び戦略的SWOT分析
    Summary Petrodorado Energy Ltd. (Petrodorado), formerly Cap-Link Ventures Ltd., is a crude oil and natural gas exploration company that carries out the acquisition, exploration and development of oil and gas properties in Colombia, Peru and Paraguay. The company concentrates primarily on developing …
  • China National Petroleum Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China National Petroleum Corpor …
  • Cymbet Corporation:企業のM&A・提携動向(発電分野)
    Summary Cymbet Corporation (Cymbet) is a clean technology company that offers solid-state energy storage solutions for microelectronic systems. The company offers products which include EnerChip, EnerChip solid state batteries, EnerChip bare die, EnerChip RTC and evaluation kits. Its devices enable …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆